https://ijpcr.net/ijpcr/issue/feedInternational Journal of Pharmacology and Clinical Research (IJPCR)2021-11-23T15:17:07+00:00Dr.N.Sriramijpcreditor@gmail.comOpen Journal Systems<p><strong><em>International Journal of Pharmacology and Clinical Research (IJPCR) </em></strong>is a peer-reviewed, quarterly official international journal allowing access to abstracts<strong> </strong>and<strong> </strong>full-text. The journal is devoted to the promotion of pharmaceutical sciences and related disciplines (Pharmacology, Biopharmaceutics, Pharmacokinetics, Pharmaceutical Medicinal Chemistry, Computational Chemistry & Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmaceutical Analysis, Pharmacy Practice, Clinical & Hospital Pharmacy, Cell Biology, Genomics & Proteomics, Pharmacogenomics, Bioinformatics including biotechnology, cell & molecular biology, Pharmaceutical biotechnology/microbiology, medical and other life sciences).</p> <p><strong>ISSN</strong> - <strong><em>International Journal of Pharmacology and Clinical Research (IJPCR)</em></strong></p> <p><strong>Online</strong>:<strong> </strong>2521-2206</p> <p><strong><em>International Journal of Pharmacology and Clinical Research </em></strong>seeks to foster multidisciplinary research and collaboration among scientists, pharmaceutical industries and healthcare sector as well as provide an international forum for the communication and evaluation of data, methods and opinions in pharmaceutical sciences and related disciplines. Although primarily devoted to original research papers, the journal particularly welcomes reviews on current topics of special interest and relevance. All manuscripts will be subjected to rapid peer review. Those of high quality (not previously published and not already under consideration for publication) will be published.</p>https://ijpcr.net/ijpcr/article/view/160A retrospective evaluation of prescription pattern on chronic kidney disease patients in a tertiary care hospital2021-11-23T15:17:07+00:00Keerthi Yurenikka Jjyurenikka26@gmail.comAbdulla Mjyurenikka26@gmail.comPaul McGrath Rjyurenikka26@gmail.comSowmya Tjyurenikka26@gmail.comDr. Tamiljothi Ejyurenikka26@gmail.com<p><strong>Background:</strong><strong> CKD is known as abnormalities in structure of kidney or functioning of </strong>Glomerular Filtration Rate (GFR) <60 ml/min./1.73m<sup>2</sup> for at least three month duration. Various complications include hypertension, anemia, diabetes mellitus and bone mineral related disorders. The objective of work is to study the prescription pattern, compare prescribing indicators with standard and evaluate of rational prescribing of drugs. <strong>Methods:</strong> A retrospective observational analysis conducted on chronic kidney disease (CKD) patients from the department of general medicine, of Government District Headquarters Hospital, Virudhunagar. <strong>Result:</strong> Study included 102 prescriptions, of which 895 drugs were totally given. Average number of drugs per encounter was 8.77. Percentage of drugs in generic name was 88.83; percentage of drug prescribed from national list of essential medicine was 92.96. Percentage of encounters with antibiotic and injection were 47.06, 83.33 respectively. <strong>Conclusion:</strong> Antihypertensive drugs are prescribed more commonly for the patients, in which Calcium Channel Blockers are given frequently than ACE inhibitors or Angiotensin – II Receptor blockers. The prescribing indicators deviate from WHO optimal values which should be rectified to improve the standards of treatment and patient care. A better counseling would alleviate the clinical conditions of the community to improve quality of care.</p> <p> </p>2021-11-23T15:17:07+00:00Copyright (c) 2021 International Journal of Pharmacology and Clinical Research (IJPCR)